Kinneret Savitsky Selected Research

Amphetamine (Amfetamine)

1/2009

BL-1020: a novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kinneret Savitsky Research Topics

Disease

2	Catalepsy 01/2009 - 05/2008
1	Schizophrenia (Dementia Praecox) 01/2009
1	Prostatic Neoplasms (Prostate Cancer) 05/2002

Drug/Important Bio-Agent (IBA)

2	Perphenazine (Trilafon)FDA LinkGeneric 01/2009 - 05/2008
2	gamma-Aminobutyric Acid (GABA)IBA 01/2009 - 05/2008
2	Antipsychotic Agents (Antipsychotics)IBA 01/2009 - 05/2008
1	perphenazine GABA esterIBA 01/2009
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2009
1	Dopamine (Intropin)FDA LinkGeneric 01/2009
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2009
1	Butyric Acid (Butanoic Acid)IBA 01/2009
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 05/2008
1	Fluphenazine (Prolixin)FDA LinkGeneric 05/2008
1	EstersIBA 05/2008
1	ProlactinIBA 05/2008
1	Tissue Kallikreins (Tissue Kallikrein)IBA 05/2002